Best in Biotech 24 Oct 2023 Seven molecular glue startups looking to stick around in the biotech industry Since they were discovered around three decades ago, molecular glues have come a very long way as a therapeutic option for several different disease areas, including cancer and neurodegenerative disorders. Now, there are a rising number of molecular glue companies hoping to show clinical success with their candidates. The term molecular glue refers to a […] October 24, 2023 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 23 Oct 2023 Top 10 tips from an expert on how to start an early phase clinical trial Early phase clinical trials can be complicated and time-consuming, with their success dependent on several different factors. The outcome of these early phase clinical trials will determine the future of your drug development project, and so ensuring safety and efficiency at every step since the start is vital for its overall success. The clinical operations […] October 23, 2023 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 20 Oct 2023 Is Africa ready to become the next big biopharma and vaccine manufacturing destination? Localizing pharma manufacturing worldwide is an extremely important step, and it holds particular significance for Africa. The continent is more vulnerable to disease burdens and lags behind other continents when it comes to vaccine and general healthcare access. Localized manufacturing could help people in Africa gain easier and more affordable access to vaccines and other […] October 20, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 20 Oct 2023Beyond Biotech podcast 68 – rejuvenation with stem cells This week, our guest on the podcast is Mark Kotter, founder of clock.bio. clock.bio, a sister company to bit.bio, which Kotter also founded and is the CEO of, aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells […] October 20, 2023 Share WhatsApp Twitter Linkedin Email
In Depth 19 Oct 2023 Biotech’s battle against NASH: The ongoing pursuit of an effective treatment NASH is one of the most common reasons for a patients receiving a liver transplant. The condition is a severe form of non-alcoholic fatty liver disease (NAFLD), whereby fat builds up on the liver, potentially leading to liver damage or cirrhosis. And, yet, despite the severity of the disease, there are still no approved NASH […] October 19, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 16 Oct 2023 Blockchain-based biotech: is this a viable financing method? At a time when biotechs are scrambling to raise funds, a new way for startups to secure investments is emerging: leveraging cryptocurrency. The motive behind decentralized financing seems pretty ambitious – to democratize funding in healthcare. But does it live up to the hype? With VitaDAO – a decentralized collective that funds early-stage startups looking […] October 16, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Oct 2023 How close are we to a cure for metastatic breast cancer? Currently considered an incurable disease, there is a lot of work being done around developing better treatment options for metastatic breast cancer, and, ultimately, a cure. Numerous promising candidates are in clinical trials, all with the hope of progressing toward U.S. Food and Drug Administration (FDA) approval. According to the World Health Organization (WHO), 2.3 […] October 13, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 13 Oct 2023Beyond Biotech podcast 67 – natural killer cells This week, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D. The company has demonstrated the potential for efficacy and safety with natural killer (NK) cells in two cancer clinical trials. In August, the company announced FDA clearance for an IND for lupus – marking a first for an allogeneic, off-the-shelf NK or CAR-T cell […] October 13, 2023 Share WhatsApp Twitter Linkedin Email
In Depth 12 Oct 2023 Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated? The immune system protects our bodies from foreign invaders, but sometimes, when it malfunctions, it can result in life-threatening autoimmune disorders. But what if the immune system could be regulated to counter these diseases? Immunometabolism, an emerging field in therapeutics, aims to rein in autoimmunity altogether. According to Neil Weir, chief executive officer (CEO) of […] October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 11 Oct 2023 Project NextGen: The U.S. government’s $5 billion initiative to stay one step ahead of COVID-19 When SARS-CoV-2 spread out of Wuhan, China, to the rest of the world, it became only the fifth pandemic to be documented since the 1918 flu pandemic. As the entire world went into lockdown, waiting in anticipation for a miracle treatment, the scientific community accomplished what had never been accomplished before, developing first-of-their-kind vaccines against […] October 11, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2023 Bridging Science and Art: Five bioartists you should know about Bioartists bridge art, born out of creativity and abstract thoughts, and science, which is rooted in facts, laws and logic, as a means of self-expression. The term bioart was coined by Brazilian-American artist Eduardo Kac, who implanted a microchip in his ankle on live television, and registered himself in a pet database, as both the […] October 10, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 Oct 2023 The biggest private biotech investments in September 2023 The companies Generate Biomedicines, Apollo Therapeutics and Nimbus Therapeutics bagged the biggest biotech investments in September 2023. Around the world, drug discovery and oncology players attracted the biggest funding rounds. As we made our way into autumn in the Northern Hemisphere, September 2023 saw some big funding rounds take place around the globe, particularly within […] October 9, 2023 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email